Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

New Alzheimer's study to combine drugs targeting amyloid and tau proteins

A new study will combine an Alzheimer's medication that slows disease progression in some patients with two other drugs to see if their effects can be amplified.

12 Oct 2023

Unlocking hope: Promising treatments for cognitive impairment in HIV patients on the horizon

Researchers examine the mechanisms responsible for the increased risk of neurocognitive impairment in HIV patients and explore potential treatments.

12 Oct 2023

World-first clinical trial offers new hope in the treatment of mild cognitive impairment among older people

Western Sydney University's NICM Health Research Institute has led a world-first clinical trial in Australia that offers new hope in the treatment of mild cognitive impairment (MCI) among older people.

11 Oct 2023

UArizona to train next generation of Alzheimer's researchers with prestigious NIH grant

A prestigious National Institute on Aging training grant to develop a future workforce of research scientists in the field of Alzheimer's disease and related dementias was awarded to researchers at the Center for Innovation in Brain Science at the University of Arizona Health Sciences.

11 Oct 2023

Subtle test deficits may predict risk of developing mild cognitive impairment

Among people who report memory and thinking problems, some show no signs of a problem on standard tests, while others have subtle declines on their tests.

11 Oct 2023

New consensus practice guideline published for clinicians on the determination of brain death

New guidance has been issued for clinicians on the determination of brain death, also known as death by neurologic criteria.

11 Oct 2023

Study identifies pathways explaining racial/ethnic and socio-economic disparities in dementia

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 18, entitled, "Pathways explaining racial/ethnic and socio-economic disparities in dementia incidence: the UK Biobank study."

11 Oct 2023

Study sheds light on genetic influences on fatty acid use in minority populations

University of Virginia School of Medicine researchers have obtained new insights into how African-American and Hispanic-American people's genes influence their ability to use Omega-3 and Omega-6 fatty acids for good health.

11 Oct 2023

Specific navigational errors may indicate early signs of Alzheimer’s disease

People with early Alzheimer's disease have difficulty turning when walking, according to a new study using virtual reality led by UCL researchers.

11 Oct 2023

New AI model can identify neuroanatomical regions vulnerable to age-related changes

The aging brain undergoes structural and cellular changes that can impact function and increase susceptibility to neurodegenerative disorders like Alzheimer's disease.

11 Oct 2023

Advanced neuroimaging reveals surprising link between glaucoma and Alzheimer's disease

The overlap in clinical and magnetic resonance imaging (MRI) findings between Alzheimer's disease and glaucoma.

9 Oct 2023

Groundbreaking research may provide hope to better understand and prevent Alzheimer’s disease

As of 2020, approximately 5.8 million Americans suffer from Alzheimer’s disease, but recent groundbreaking research may provide hope to better understand and potentially prevent this devastating condition.

9 Oct 2023

Graphene oxide offers a promising new approach to treating Alzheimer's disease

A probable early driver of Alzheimer's disease is the accumulation of molecules called amyloid peptides. These cause cell death, and are commonly found in the brains of Alzheimer’s patients. Researchers at Chalmers University of Technology, have now shown that yeast cells that accumulate these misfolded amyloid peptides can recover after being treated with graphene oxide nanoflakes.

9 Oct 2023

Non-invasive eye exam could be a valuable tool for early detection of cerebral small vessel disease

A research team led by the Keck School of Medicine of USC has discovered that a non-invasive eye exam may be a possible tool for screening Black Americans and other people from underdiagnosed and high-risk populations for cerebral small vessel disease, a major contributor to cognitive impairment and dementia.

6 Oct 2023

Researchers identify two main pathways involved in Alzheimer's disease

Dementia, which includes Alzheimer's disease, currently affects around 1.8 million people in Germany. The exact cause has not yet been clarified, but genetic factors play a significant role in the development of the disease.

6 Oct 2023

Study helps explain how the brain adapts during a critical period of adulthood

Developing brains become shaped by the sights, sounds, and experiences of early life. The brain's circuits grow more stable as we age.

5 Oct 2023

New antibody shows promise in reducing tau proteins associated with Alzheimer's disease

A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alzheimer's disease.

5 Oct 2023

Groundbreaking research focuses on brain health monitoring, early detection of neurodegenerative diseases

Associate Professor at the University of Oulu Teemu Myllylä, a leading expert in biomedical engineering, recently discussed his team's groundbreaking work in brain health monitoring and early detection of neurodegenerative diseases at the recent 6G-enabled sustainable society event.

4 Oct 2023

Graphene oxide nanoflakes may help treat Alzheimer's disease

A probable early driver of Alzheimer's disease is the accumulation of molecules called amyloid peptides. These cause cell death, and are commonly found in the brains of Alzheimer's patients.

4 Oct 2023

Study links high and low levels of "good" cholesterol with dementia risk

Having either high or low levels of high-density lipoprotein (HDL) cholesterol, or "good" cholesterol, is tied to a small increased risk of dementia in older adults, according to a study published in the October 4, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

4 Oct 2023

Alzheimer's Disease News and Research

Further Reading

New Alzheimer's study to combine drugs targeting amyloid and tau proteins

Unlocking hope: Promising treatments for cognitive impairment in HIV patients on the horizon

World-first clinical trial offers new hope in the treatment of mild cognitive impairment among older people

UArizona to train next generation of Alzheimer's researchers with prestigious NIH grant

Subtle test deficits may predict risk of developing mild cognitive impairment

New consensus practice guideline published for clinicians on the determination of brain death

Study identifies pathways explaining racial/ethnic and socio-economic disparities in dementia

Study sheds light on genetic influences on fatty acid use in minority populations

Specific navigational errors may indicate early signs of Alzheimer’s disease

New AI model can identify neuroanatomical regions vulnerable to age-related changes

Advanced neuroimaging reveals surprising link between glaucoma and Alzheimer's disease

Groundbreaking research may provide hope to better understand and prevent Alzheimer’s disease

Graphene oxide offers a promising new approach to treating Alzheimer's disease

Non-invasive eye exam could be a valuable tool for early detection of cerebral small vessel disease

Researchers identify two main pathways involved in Alzheimer's disease

Study helps explain how the brain adapts during a critical period of adulthood

New antibody shows promise in reducing tau proteins associated with Alzheimer's disease

Groundbreaking research focuses on brain health monitoring, early detection of neurodegenerative diseases

Graphene oxide nanoflakes may help treat Alzheimer's disease

Study links high and low levels of "good" cholesterol with dementia risk

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News